Common back-pain drug may be linked to higher dementia risk, large study finds

Medical Alert: If you or a loved one experience sudden confusion, severe memory loss, or cognitive difficulties, seek medical attention promptly as these can be signs of urgent neurological conditions.

Gabapentin Use and Dementia Risk: What You Need to Know First

Gabapentin, a medication frequently prescribed for chronic low-back pain, has been linked in a large U.S. study to an increased risk of dementia and mild cognitive impairment (MCI). This finding is critical for millions of Americans relying on this drug to manage persistent pain.

Determining Your Risk: Consider Age and Prescription Frequency

The association between gabapentin use and cognitive decline is not uniform across all patients. Younger adults, particularly those aged 35 to 49, face more than double the risk of developing dementia compared to non-users with similar pain conditions. Their risk of mild cognitive impairment is even higher—more than triple. Adults aged 50 to 64 also show significantly elevated risks, while those under 35 do not appear to have increased risk based on current data.

Moreover, the number of gabapentin prescriptions correlates strongly with cognitive risk. Those with six or more prescriptions saw a 29% higher chance of dementia diagnosis within 10 years, and this risk rises with more frequent use. Patients with 12 or more prescriptions experienced up to a 40% increased dementia risk and a 65% higher chance of MCI.

Check Your Medicine Cabinet: Is Gabapentin Part of Your Pain Management?

If gabapentin is part of your treatment plan for chronic back pain, understanding your cognitive health risks is essential. Gabapentin’s side effects typically include dizziness, tiredness, fluid retention, and dry mouth, but the potential for long-term cognitive effects requires careful consideration.

Health professionals emphasize that this study is observational. It identifies a strong link but does not prove that gabapentin directly causes dementia. Other factors may contribute, and the increased risk remains a signal for close monitoring rather than immediate alarm.

What To Do Now

If you are prescribed gabapentin, discuss with your healthcare provider the benefits and risks in your specific case, especially if you are under 65 or have had multiple prescriptions. Monitoring cognitive function during ongoing treatment is advisable to catch any early signs of decline.

Chronic back pain management involves complex decisions balancing pain relief and safety. This new evidence adds an important dimension to those discussions.

Here are the 10 factors linked to gabapentin and cognitive risks. Number 7 is the one that changes how doctors consider treatment plans.

Continue Reading on the Next Page